Evolent Health (EVH) Tops Q2 EPS by 5c, Rases Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Evolent Health Announces Second Quarter 2022 Results
August 2, 2022 4:10 PM EDTAnnounces Four Operating Partner Additions
WASHINGTON, Aug. 2, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended June 30, 2022.
Highlights from the second quarter of 2022 announcement include:
Quarter ended June 30, 2022:
Revenue of $319.9 million, an increase of $97.9 million, or 44.1%, from the three months ended June 30, 2021.Net loss attributable to common... More